Repetitive administration of rituximab can achieve and maintain clinical remission in patients with MCD or FSGS

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

Extent: Online-Ressource

Language: Deutsch

Notes: Köln, Universität zu Köln, Dissertation, 2024

Classification: Medizin, Gesundheit

Event: Veröffentlichung

(where): Köln

(who): Universitäts- und Stadtbibliothek Köln

(when): 2024

Creator: Thomas, Osterholt

Contributor: Brinkkötter, Paul Thomas
Borchmann, Peter

URN: urn:nbn:de:hbz:38-726963

Rights: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:55 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Thomas, Osterholt
Brinkkötter, Paul Thomas
Borchmann, Peter
Universitäts- und Stadtbibliothek Köln

Time of origin

2024

Other Objects (12)

Repetitive administration of rituximab can achieve and maintain clinical remission in patients with MCD or FSGS

GPA: Remission nach Cyclophosphamid und Rituximab wahrscheinlicher

Time to achieve remission determines time to be in remission

Male rock hyraxes that maintain an isochronous song rhythm achieve higher reproductive success

Clinical and laboratory remission with rituximab in anti-MuSK-positive myasthenia gravis

Rituximab, Mycophenolic Acid, and Calcineurin Inhibitors Achieve Long-Term Remission in Pediatric Focal Segmental Glomerulosclerosis with Steroid-Resistant and Frequently Relapsing Nephrotic Syndrome: A Report of Two Cases

Lenvatinib Can Overcome Immune Resistance in Head and Neck Cancer and Achieve Durable Remission

Sustained clinical remission under infliximab/rituximab combination therapy in a patient with granulomatosis with polyangiitis

Fecal microbiota transplantation to maintain remission in Crohn’s disease: a pilot randomized controlled study

Budesonide orodispersible tablets maintain remission in a randomized, placebo-controlled trial of patients with eosinophilic esophagitis

Early treatment regimens achieve sustained virologic remission in infant macaques infected with SIV at birth

Repetitive administration of rituximab can achieve and maintain clinical remission in patients with MCD or FSGS

GPA: Remission nach Cyclophosphamid und Rituximab wahrscheinlicher

Time to achieve remission determines time to be in remission

Male rock hyraxes that maintain an isochronous song rhythm achieve higher reproductive success

Clinical and laboratory remission with rituximab in anti-MuSK-positive myasthenia gravis

Rituximab, Mycophenolic Acid, and Calcineurin Inhibitors Achieve Long-Term Remission in Pediatric Focal Segmental Glomerulosclerosis with Steroid-Resistant and Frequently Relapsing Nephrotic Syndrome: A Report of Two Cases

Lenvatinib Can Overcome Immune Resistance in Head and Neck Cancer and Achieve Durable Remission

Sustained clinical remission under infliximab/rituximab combination therapy in a patient with granulomatosis with polyangiitis

Fecal microbiota transplantation to maintain remission in Crohn’s disease: a pilot randomized controlled study

Budesonide orodispersible tablets maintain remission in a randomized, placebo-controlled trial of patients with eosinophilic esophagitis

Early treatment regimens achieve sustained virologic remission in infant macaques infected with SIV at birth

Repetitive administration of rituximab can achieve and maintain clinical remission in patients with MCD or FSGS

GPA: Remission nach Cyclophosphamid und Rituximab wahrscheinlicher

Time to achieve remission determines time to be in remission

Male rock hyraxes that maintain an isochronous song rhythm achieve higher reproductive success

Clinical and laboratory remission with rituximab in anti-MuSK-positive myasthenia gravis

Rituximab, Mycophenolic Acid, and Calcineurin Inhibitors Achieve Long-Term Remission in Pediatric Focal Segmental Glomerulosclerosis with Steroid-Resistant and Frequently Relapsing Nephrotic Syndrome: A Report of Two Cases

Lenvatinib Can Overcome Immune Resistance in Head and Neck Cancer and Achieve Durable Remission

Sustained clinical remission under infliximab/rituximab combination therapy in a patient with granulomatosis with polyangiitis

Fecal microbiota transplantation to maintain remission in Crohn’s disease: a pilot randomized controlled study

Budesonide orodispersible tablets maintain remission in a randomized, placebo-controlled trial of patients with eosinophilic esophagitis

Early treatment regimens achieve sustained virologic remission in infant macaques infected with SIV at birth

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Repetitive administration of rituximab can achieve and maintain clinical remission in patients with MCD or FSGS

Object Details

Classification and Topics

Contributors, Places and Time

Further information

Data provider

Associated

Time of origin

Other Objects (12)

Repetitive administration of rituximab can achieve and maintain clinical remission in patients with MCD or FSGS

GPA: Remission nach Cyclophosphamid und Rituximab wahrscheinlicher

Time to achieve remission determines time to be in remission

Male rock hyraxes that maintain an isochronous song rhythm achieve higher reproductive success

Clinical and laboratory remission with rituximab in anti-MuSK-positive myasthenia gravis

Rituximab, Mycophenolic Acid, and Calcineurin Inhibitors Achieve Long-Term Remission in Pediatric Focal Segmental Glomerulosclerosis with Steroid-Resistant and Frequently Relapsing Nephrotic Syndrome: A Report of Two Cases

Lenvatinib Can Overcome Immune Resistance in Head and Neck Cancer and Achieve Durable Remission

Sustained clinical remission under infliximab/rituximab combination therapy in a patient with granulomatosis with polyangiitis

Sustained clinical remission under infliximab/rituximab combination therapy in a patient with granulomatosis with polyangiitis

Fecal microbiota transplantation to maintain remission in Crohn’s disease: a pilot randomized controlled study

Budesonide orodispersible tablets maintain remission in a randomized, placebo-controlled trial of patients with eosinophilic esophagitis

Early treatment regimens achieve sustained virologic remission in infant macaques infected with SIV at birth

Repetitive administration of rituximab can achieve and maintain clinical remission in patients with MCD or FSGS

GPA: Remission nach Cyclophosphamid und Rituximab wahrscheinlicher

Time to achieve remission determines time to be in remission

Male rock hyraxes that maintain an isochronous song rhythm achieve higher reproductive success

Clinical and laboratory remission with rituximab in anti-MuSK-positive myasthenia gravis

Rituximab, Mycophenolic Acid, and Calcineurin Inhibitors Achieve Long-Term Remission in Pediatric Focal Segmental Glomerulosclerosis with Steroid-Resistant and Frequently Relapsing Nephrotic Syndrome: A Report of Two Cases

Lenvatinib Can Overcome Immune Resistance in Head and Neck Cancer and Achieve Durable Remission

Sustained clinical remission under infliximab/rituximab combination therapy in a patient with granulomatosis with polyangiitis

Sustained clinical remission under infliximab/rituximab combination therapy in a patient with granulomatosis with polyangiitis

Fecal microbiota transplantation to maintain remission in Crohn’s disease: a pilot randomized controlled study

Budesonide orodispersible tablets maintain remission in a randomized, placebo-controlled trial of patients with eosinophilic esophagitis

Early treatment regimens achieve sustained virologic remission in infant macaques infected with SIV at birth

Repetitive administration of rituximab can achieve and maintain clinical remission in patients with MCD or FSGS

GPA: Remission nach Cyclophosphamid und Rituximab wahrscheinlicher

Time to achieve remission determines time to be in remission

Male rock hyraxes that maintain an isochronous song rhythm achieve higher reproductive success

Clinical and laboratory remission with rituximab in anti-MuSK-positive myasthenia gravis

Rituximab, Mycophenolic Acid, and Calcineurin Inhibitors Achieve Long-Term Remission in Pediatric Focal Segmental Glomerulosclerosis with Steroid-Resistant and Frequently Relapsing Nephrotic Syndrome: A Report of Two Cases

Lenvatinib Can Overcome Immune Resistance in Head and Neck Cancer and Achieve Durable Remission

Sustained clinical remission under infliximab/rituximab combination therapy in a patient with granulomatosis with polyangiitis

Sustained clinical remission under infliximab/rituximab combination therapy in a patient with granulomatosis with polyangiitis

Fecal microbiota transplantation to maintain remission in Crohn’s disease: a pilot randomized controlled study

Budesonide orodispersible tablets maintain remission in a randomized, placebo-controlled trial of patients with eosinophilic esophagitis

Early treatment regimens achieve sustained virologic remission in infant macaques infected with SIV at birth

Related objects

Reset password